Project Details
Description
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
| Status | Finished |
|---|---|
| Effective start/end date | 3/24/16 → 3/24/21 |
Funding
- SHIRE HUMAN GENETIC THERAPIES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.